The Russian vaccine from coronavirus infection “Satellite V” could be approved by the European Medicine Agency (EMA) if it was evaluated only at medical records. This was stated by the member of the Bundestag Committee on International Affairs from “Alternative for Germany” Peter quickly in a conversation with Izvestia.
Quickly believes that the recognition of the Russian drug is inhibited due to political and economic factors. According to him, that EMA protects the market so that large Western pharmaceutical companies can sell their drugs without competition.
politician added that the agency does not want to ensure the influx of foreign currency to Russia. “If EMA estimates vaccines purely from a medical point of view,” satellite V “would have long been approved in the EU,” he said.
Earlier, Russian President Vladimir Putin at an annual major press conference declared the need for mutual recognition of vaccines. The head of state indicated that the victory over the Pandemic COVID-19 is impossible without recognizing vaccines by leading global countries.